Showing results (191-200 of 308) with videos related to

Sort By:
Pageof 31
Annals of the Rheumatic Diseases|October 30, 2012
Smoking and overweight determine the likelihood of developing rheumatoid arthritisMaria J H de Hair, Robert B M Landewé, Marleen G H van de Sande, et al.
Arthritis and Rheumatism|August 1, 2007
Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesisTrieneke C G Timmer, Belinda Baltus, Mark Vondenhoff, et al.
Arthritis and Rheumatism|March 1, 2007
Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destructionDavid A Brown, John Moore, Heiko Johnen, et al.
Rheumatology (Oxford, England)|May 15, 2016
Reduced CLEC9A expression in synovial tissue of psoriatic arthritis patients after adalimumab therapyMaria I Ramos, Marcel B M Teunissen, Boy Helder, et al.
Annals of the Rheumatic Diseases|December 4, 2014
The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblastsKerstin Klein, Pawel A Kabala, Aleksander M Grabiec, et al.
Rheumatology (Oxford, England)|February 23, 2018
Class 3 semaphorins modulate the invasive capacity of rheumatoid arthritis fibroblast-like synoviocytesMan Wai Tang, Beatriz Malvar Fernández, Simon P Newsom, et al.
Plos One|January 25, 2015
Two novel α7 nicotinic acetylcholine receptor ligands: in vitro properties and their efficacy in collagen-induced arthritis in miceMarjolein A van Maanen, Roger L Papke, Frieda A Koopman, et al.
The Journal of Rheumatology|September 3, 2011
OMERACT 10 Sharp Symposium: important findings in examination of imaging methods for measurement of joint damage in rheumatoid arthritisVibeke Strand, Sarah R Kingsbury, Thasia Woodworth, et al.
Annals of the Rheumatic Diseases|May 8, 2012
Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)Maxime Dougados, Karsten Kissel, Tom Sheeran, et al.
International Journal of Molecular Sciences|February 11, 2023
Mammalian Glycosylation Patterns Protect Citrullinated Chemokine MCP-1/CCL2 from Partial DegradationOlexandr Korchynskyi, Ken Yoshida, Nataliia Korchynska, et al.
Pageof 31